From idea to access: Designing early-phase trials that work in practice

Professor Sarah Brown
Published:
Sign up to join the conversation
Members only

CARP has successfully developed and delivered innovative early-phase trials, offering over 1,400 people with myeloma access to new treatments. This is an incredible achievement for an early-phase programme. At CTRU, we have established both methodological and operational expertise in designing and delivering complex trials through CARP.

Sign up and become a member of the Myeloma UK HCP Hub

Access exclusive content like this and join in the conversation.

Sign up now

Already have an account?

Login